APA (7th ed.) Citation

AN, F., J, J., TC, K., RE, B., AI, T., MA, B., . . . DM, G. (2014). The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A gynecologic Oncology Group study. Gynecologic oncology, 132(3), 560. https://doi.org/10.1016/j.ygyno.2013.11.016

Chicago Style (17th ed.) Citation

AN, Fader, Java J, Krivak TC, Bristow RE, Tergas AI, Bookman MA, Armstrong DK, Tanner EJ, and Gershenson DM. "The Prognostic Significance of Pre- and Post-treatment CA-125 in Grade 1 Serous Ovarian Carcinoma: A Gynecologic Oncology Group Study." Gynecologic Oncology 132, no. 3 (2014): 560. https://doi.org/10.1016/j.ygyno.2013.11.016.

MLA (9th ed.) Citation

AN, Fader, et al. "The Prognostic Significance of Pre- and Post-treatment CA-125 in Grade 1 Serous Ovarian Carcinoma: A Gynecologic Oncology Group Study." Gynecologic Oncology, vol. 132, no. 3, 2014, p. 560, https://doi.org/10.1016/j.ygyno.2013.11.016.